Table 7

Bloodborne data of 19 resistance trained men receiving placebo or supplement in a cross-over design.

Condition

*Lactate

(mmol∙L^-1)

Nitrate/Nitrite

(μmol∙L^-1)

Malondialdehyde

(μmol∙L^-1)

Baseline Pre

1.85 ± 0.12

22.18 ± 2.43

0.71 ± 0.06

Baseline Post

5.97 ± 0.33

22.11 ± 2.43

0.76 ± 0.09

Placebo Pre

2.03 ± 0.22

17.74 ± 1.57

0.75 ± 0.08

Placebo Post

6.52 ± 0.34

19.90 ± 1.67

0.82 ± 0.10

GlycoCarn^® Pre

1.81 ± 0.13

22.72 ± 3.39

0.73 ± 0.06

GlycoCarn^® Post

6.62 ± 0.41

21.68 ± 2.39

0.63 ± 0.04

SUPP1 Pre

2.08 ± 0.14

23.61 ± 3.46

0.58 ± 0.07

SUPP1 Post

7.51 ± 0.43

23.57 ± 3.21

0.80 ± 0.11

SUPP2 Pre

1.89 ± 0.16

18.89 ± 2.29

0.80 ± 0.12

SUPP2 Post

7.20 ± 0.37

19.89 ± 2.25

0.81 ± 0.11

SUPP3 Pre

1.53 ± 0.12

21.92 ± 2.91

0.66 ± 0.08

SUPP3 Post

7.10 ± 0.31

22.33 ± 2.69

0.79 ± 0.08

Data are mean ± SEM.

No statistically significant interactions or condition effects noted for any variable (p > 0.05).

* Time main effect for lactate (p < 0.0001).

Pre = before exercise; Post = after exercise

Bloomer et al. Journal of the International Society of Sports Nutrition 2010 7:16   doi:10.1186/1550-2783-7-16